Female adult mouse cardiomyocytes are protected against oxidative stress

Hypertension

Volumn 55, Issue 5, 2010, Pages 1172-1178

  Wang, Fangfei ^a   He, Quan ^a   Sun, Ying ^a,b   Dai, Xiangguo ^a   Yang, Xiao Ping ^a  

^a HENRY FORD HOSPITAL   (United States)

^b NORTH CHINA COAL MEDICAL COLLEGE   (China)

Author keywords

Apoptosis; Estrogen; Mice; Myocytes; Oxidative stress; Signal transduction

Indexed keywords

CASPASE 3; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLYCOGEN SYNTHASE KINASE 3BETA; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; LIPOCORTIN 5; PROTEIN BCL 2; PROTEIN KINASE B;

ANIMAL CELL; ARTICLE; CARDIOVASCULAR RISK; CELL DEATH; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HEART CELL CULTURE; HEART MUSCLE CELL; HEART PROTECTION; MALE; MENOPAUSE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE;

ANIMALS; ANTICOAGULANTS; CARDIOVASCULAR DISEASES; CASPASE 3; CELL DEATH; CELL SURVIVAL; ESTROGEN RECEPTOR ALPHA; FEMALE; HEPARIN; HUMANS; HYDROGEN PEROXIDE; L-LACTATE DEHYDROGENASE; MALE; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; OXIDATIVE STRESS; PREMENOPAUSE; SEX CHARACTERISTICS;

EID: 77951499165     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.150839     Document Type: Article

References (35)

1. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science. 2005;308:1583-1587. (Pubitemid 40807497)
2. Luczak ED, Leinwand LA. Sex-based cardiac physiology. Annu Rev Physiol. 2009;71:1-18.
3. Wang F, Keimig T, He Q, Ding J, Zhang Z, Pourabdollah-Nejad S, Yang XP. Augmented healing process in female mice with acute myocardial infarction. Gend Med. 2007;4:230-247. (Pubitemid 350082738)
4. Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res. 1998;82:1111-1129. (Pubitemid 28311120)
5. Pelzer T, Schumann M, Neumann M, deJager T, Stimpel M, Serfling E, Neyses L. 17/3-Estradiol prevents programmed cell death in cardiac myocytes. Biochem Biophys Res Commun. 2000;268:192-200. (Pubitemid 30116632)
6. Peter I, Huggins GS, Shearman AM, Pollak A, Schmid CH, Cupples LA, Demissie S, Patten RD, Karas RH, Housman DE, Mendelsohn ME, Vasan RS, Benjamin EJ. Age-related changes in echocardiographic measurements: association with variation in the estrogen receptor-a gene. Hypertension. 2007;49:1000-1006. (Pubitemid 351664311)
7. Shearman AM, Cooper JA, Kotwinski PJ, Miller GJ, Humphries SE, Ardlie KG, Jordan B, Irenze K, Lunetta KL, Schuit SC, Uitterlinden AG, Pols HA, Demissie S, Cupples LA, Mendelsohn ME, Levy D, Housman DE. Estrogen receptor agene variation is associated with risk of myocardial infarction in more than seven thousand men from five cohorts. Circ Res. 2006;98:590-592. (Pubitemid 43755276)
8. Sugden PH, Clerk A. Akt like a woman: gender differences in susceptibility to cardiovascular disease [editorial]. Circ Res. 2001;88:975-977. (Pubitemid 34137106)
9. Sugden PH, Fuller SJ, Weiss SC, Clerk A. Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. Br J Pharmacol. 2008; 153(suppl 1):S137-S153. (Pubitemid 351341012)
10. Menon B, Johnson JN, Ross RS, Singh M, Singh K. Glycogen synthase kinase-3/3 plays a pro-apoptotic role in/3-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: role of/31 integrins. J Mol Cell Cardiol. 2007;42:653-661. (Pubitemid 46349131)
11. Kurokawa M, Kornbluth S. Caspases and kinases in a death grip. Cell. 2009;138:838-854.
12. Chang HY, Yang X. Proteases for cell suicide: functions and regulation of caspases. Microbiol Mol Biol Rev. 2000;64:821-846. (Pubitemid 32475932)
13. Das DK, Maulik N. Conversion of death signal into survival signal by redox signaling. Biochemistry (Mosc). 2004;69:10-17.
14. Mitcheson JS, Hancox JC, Levi AJ. Cultured adult cardiac myocytes: future applications, culture methods, morphological and electrophysiological properties. Cardiovasc Res. 1998;39:280-300.
15. Dhingra S, Sharma AK, Arora RC, Slezak J, Singal PK. IL-10 attenuates TNF-a-induced NF kappaB pathway activation and cardiomyocyte apoptosis. Cardiovasc Res. 2009;82:59-66.
16. Del Re DP, Miyamoto S, Brown JH. Focal adhesion kinase as a RhoA-activable signaling scaffold mediating Akt activation and cardiomyocyte protection. J Biol Chem. 2008;283:35622-35629.
17. Camper-Kirby D, Welch S, Walker A, Shiraishi I, Setchell KD, Schaefer E, Kajstura J, Anversa P, Sussman MA. Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ Res. 2001;88:1020-1027. (Pubitemid 34137114)
18. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature. 1986;320:134-139. (Pubitemid 16105150)
19. Brouchet L, Krust A, Dupont S, Chambon P, Bayard F, Arnal JF. Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-a but not estrogen receptor-/3. Circulation. 2001;103: 423-428. (Pubitemid 32105983)
20. Wang M, Crisostomo P, Wairiuko GM, Meldrum DR. Estrogen receptor-a mediates acute myocardial protection in females. Am J Physiol Heart Circ Physiol. 2006;290:H2204-H2209. (Pubitemid 43846046)
21. Meyer MR, Haas E, Barton M. Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling. Hypertension. 2006;47:1019-1026. (Pubitemid 44289154)
22. Haynes MP, Li L, Russell KS, Bender JR. Rapid vascular cell responses to estrogen and membrane receptors. Vascul Pharmacol. 2002;38: 99-108. (Pubitemid 36401587)
23. Mugge A, Riedel M, Barton M, Kuhn M, Lichtlen PR. Endothelium independent relaxation of human coronary arteries by 17/3-oestradiol in vitro. Cardiovasc Res. 1993;27:1939-1942. (Pubitemid 23357336)
24. Sugden PH. Ras, Akt, and mechanotransduction in the cardiac myocyte. Circ Res. 2003;93:1179-1192.
25. Urata Y, Ihara Y, Murata H, Goto S, Koji T, Yodoi J, Inoue S, Kondo T. 17/3-Estradiol protects against oxidative stress-induced cell death through the glutathione/glutaredoxin-dependent redox regulation of Akt in myocardiac H9c2 cells. J Biol Chem. 2006;281:13092-13102. (Pubitemid 43855219)
26. Patten RD, Pourati I, Aronovitz MJ, Baur J, Celestin F, Chen X, Michael A, Haq S, Nuedling S, Grohe C, Force T, Mendelsohn ME, Karas RH. 17/3-Estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res. 2004; 95:692-699. (Pubitemid 39331929)
27. Matsui T, Tao J, del MF, Lee KH, Li L, Picard M, Force TL, Franke TF, Hajjar RJ, Rosenzweig A. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation. 2001;104:330-335. (Pubitemid 32666956)
28. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. PI3K/Akt and apoptosis: size matters. Oncogene. 2003;22:8983-8998. (Pubitemid 38121699)
29. Tran H, Brunet A, Griffith EC, Greenberg ME. The many forks in FOXO's road. Sci STKE. 2003;2003:RE5.
30. Miura T, Miki T. GSK-3/3, a therapeutic target for cardiomyocyte protection. Circ J. 2009;73:1184-1192.
31. Bijur GN, De SP, Jope RS. Glycogen synthase kinase-3/3 facilitates staurosporine-and heat shock-induced apoptosis: protection by lithium. J Biol Chem. 2000;275:7583-7590.
32. Gupta S, Knowlton AA. HSP60, Bax, apoptosis and the heart. J Cell Mol Med. 2005;9:51-58.
33. Duguay D, Deblois D. Differential regulation of Akt, caspases and MAP kinases underlies smooth muscle cell apoptosis during aortic remodelling in SHR treated with amlodipine. Br J Pharmacol. 2007; 151:1315-1323. (Pubitemid 47255901)
34. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC. Regulation of cell death protease caspase-9 by phosphorylation. Science. 1998;282:1318-1321. (Pubitemid 28524494)
35. Clerk A, Cole SM, Cullingford TE, Harrison JG, Jormakka M, Valks DM. Regulation of cardiac myocyte cell death. Pharmacol Ther. 2003;97: 223-261. (Pubitemid 36167840)